Combining a traditional approach to osteoporosis screening with quantitative CT starting at age 55 could reduce a woman’s lifetime risk of hip fracture while offering a cost-effective route for prevention, according to a virtual study published in Radiology this month.

Kaiser Health News reports on one facility—a 26-bed hospital in Surprise Valley, California—that is $4 million in debt—and in desperate need of outside help. The community may have found reason for hope, in the form of a 34-year-old former bodybuilder named Beau Gertz. He’s proposing a plan to use telemedicine to help boost revenue.

Radiology education has made substantial progress since its debut in the medical sphere, but students and faculty alike continue to suffer from communication barriers, high burnout risks and a lack of defined roles in the classroom, a group of administrators wrote in a compiled advice column for the Journal of the American College of Radiology.

FDA Commissioner Scott Gottlieb, MD, delivered the opening remarks at the American Society of Clinical Oncology’s 2018 annual meeting at McCormick Place in Chicago, emphasizing his organization’s goal of reducing the time needed to connect cancer patients with treatment.

Visualization dashboards in the intensive care unit (ICU) were able to decrease time spent gathering data and completing tasks, while reducing errors, according to recent research. They also improved situational awareness, guideline compliance and navigation.

Less than a week after President Donald Trump confirmed plans to proceed with tariffs on billions of dollars in Chinese imports, the Medical Imaging & Technology Alliance (MITA) has said it’s backing a bipartisan letter urging U.S. Trade Representative Robert Lighthizer to exempt nearly $3 billion worth of medical device products from Section 301 tariffs.

A police investigation is ongoing after officials found a computer and external hard drive used to store retinal images were stolen from the John A. Moran Eye Center at the University of Utah.

The majority of women with early-stage breast cancer and a mid-range score on a 21-tumor gene expression test see no added benefit from undergoing chemotherapy alongside hormone therapy during treatment, researchers reported this month at the American Society of Clinical Oncology’s annual meeting in Chicago, Illinois.